VistaGen Therapeutics, Inc.
VTGN
$3.60
-$0.83-18.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.74% | 1,726.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.74% | 1,726.67% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 5.74% | 1,726.67% | |||
| SG&A Expenses | 0.59% | 2.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.56% | 10.83% | |||
| Operating Income | -26.89% | -9.03% | |||
| Income Before Tax | -28.63% | -10.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -28.63% | -10.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.63% | -10.71% | |||
| EBIT | -26.89% | -9.03% | |||
| EBITDA | -26.87% | -9.06% | |||
| EPS Basic | -14.89% | -9.42% | |||
| Normalized Basic EPS | -14.89% | -9.44% | |||
| EPS Diluted | -14.89% | -9.42% | |||
| Normalized Diluted EPS | -14.89% | -9.44% | |||
| Average Basic Shares Outstanding | 11.96% | 1.17% | |||
| Average Diluted Shares Outstanding | 11.96% | 1.17% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||